Related Experiment Video
Updated: May 19, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
PANoptosis in environmental pollutants-induced chronic respiratory diseases
Xiaoqing Jiang1,2,3, Zhenyu Peng4, Siqi Li1,2,3
1Department of Geriatric Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, China.
Abstract:
Chronic respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, lung cancer and so on, pose a substantial global health challenge. Environmental pollutants such as cigarette smoke, particulate matter (PM), house dust mite (HDM), silicon, and volatile organic compounds (VOCs) are key contributors to these diseases, yet the underlying mechanisms remain not fully elucidated. PANoptosis, a recently identified form of programmed cell death that integrates apoptosis, pyroptosis, and necroptosis, has emerged as a crucial player in various diseases. PANoptosis is orchestrated by the PANoptosome, a multi-protein complex driven by key sensors such as Z-DNA binding protein 1 (ZBP1), absent in melanoma 2 (AIM2), and receptor-interacting protein kinase 1 (RIPK1). Increasing evidence suggests that PANoptosis contributes to lung diseases progression by exacerbating lung tissue damage in response to environmental pollutants. This review consolidates current findings on PANoptosis in pollutant-induced chronic respiratory diseases, which might provide new insights into underlying mechanisms and potential therapeutic targets.
Related Concept Videos
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

